Czech Republic Nuclear Imaging Equipment Market Outlook to 2022

2017-09-01
Price :
Published : Sep-2017
No. of Pages : 22

Czech Republic Nuclear Imaging Equipment Market Outlook to 2022

Summary

GlobalData’s new report, “Czech Republic Nuclear Imaging Equipment Market Outlook to 2022”, provides key market data on the Czech Republic Nuclear Imaging Equipment market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments – Single Photon Emission Computed Tomography (SPECT) Systems, Positron Emission Tomography (PET) Systems, Positron Emission Tomography/Computed Tomography (PET/CT) Systems, Single Photon Emission Computed Tomography/Computed Tomography (SPECT /CT) Systems and Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) Systems.

*Note: This is an on-demand report and will be delivered within 2-3 business days of the purchase (excluding weekends)

The report also provides distribution shares data for the market segment, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to market size, pipeline products, news and deals is available in the report.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size and distribution share data and analysis.

Scope

– Market size for Nuclear Imaging Equipment market segments Single Photon Emission Computed Tomography (SPECT) Systems, Positron Emission Tomography (PET) Systems, Positron Emission Tomography/Computed Tomography (PET/CT) Systems, Single Photon Emission Computed Tomography/Computed Tomography (SPECT /CT) Systems and Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) Systems.
– Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market segments. Data is provided from 2008 to 2015 and forecast to 2022.
– 2015 distribution shares data for Nuclear Imaging Equipment market.

Reasons to buy

– Develop business strategies by identifying the key market segments poised for strong growth in the future.
– Develop market-entry and market expansion strategies.
– Design competition strategies by identifying who-stands-where in the market.
– Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
– What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Filed in: Medical Device
Publisher : GlobalData
More Reports
Title Price Buy Now

Cerebral Aneurysms Global Clinical Trials Review, H2, 2018

Cerebral Aneurysms Global Clinical Trials Review, H2, 2018 Summary GlobalData's clinical trial report, "Cerebral Aneurysms Global Clinical Trials Review, H2, 2018" provides an overview of Cerebral Aneurysms clinical trials scenario. This report provides top line data relating to the clinical trials on Cerebral Aneurysms. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trial......
$2500

Bronchiolitis Global Clinical Trials Review, H2, 2018

Bronchiolitis Global Clinical Trials Review, H2, 2018 Summary GlobalData's clinical trial report, "Bronchiolitis Global Clinical Trials Review, H2, 2018" provides an overview of Bronchiolitis clinical trials scenario. This report provides top line data relating to the clinical trials on Bronchiolitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical......
$2500

Cerebral Infarction (Brain Infarction) Global Clinical Trials Review, H2, 2018

Cerebral Infarction (Brain Infarction) Global Clinical Trials Review, H2, 2018 Summary GlobalData's clinical trial report, "Cerebral Infarction (Brain Infarction) Global Clinical Trials Review, H2, 2018" provides an overview of Cerebral Infarction (Brain Infarction) clinical trials scenario. This report provides top line data relating to the clinical trials on Cerebral Infarction (Brain Infarction). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are ......
$2500

Bronchiolitis Obliterans Global Clinical Trials Review, H2, 2018

Bronchiolitis Obliterans Global Clinical Trials Review, H2, 2018 Summary GlobalData's clinical trial report, "Bronchiolitis Obliterans Global Clinical Trials Review, H2, 2018" provides an overview of Bronchiolitis Obliterans clinical trials scenario. This report provides top line data relating to the clinical trials on Bronchiolitis Obliterans. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Phar......
$2500

Cerebral Vasospasm Global Clinical Trials Review, H2, 2018

Cerebral Vasospasm Global Clinical Trials Review, H2, 2018 Summary GlobalData's clinical trial report, "Cerebral Vasospasm Global Clinical Trials Review, H2, 2018" provides an overview of Cerebral Vasospasm clinical trials scenario. This report provides top line data relating to the clinical trials on Cerebral Vasospasm. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trial......
$2500

Bronchitis Global Clinical Trials Review, H2, 2018

Bronchitis Global Clinical Trials Review, H2, 2018 Summary GlobalData's clinical trial report, "Bronchitis Global Clinical Trials Review, H2, 2018" provides an overview of Bronchitis clinical trials scenario. This report provides top line data relating to the clinical trials on Bronchitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are ......
$2500

Chronic Asthma Global Clinical Trials Review, H2, 2018

Chronic Asthma Global Clinical Trials Review, H2, 2018 Summary GlobalData's clinical trial report, "Chronic Asthma Global Clinical Trials Review, H2, 2018" provides an overview of Chronic Asthma clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Asthma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clin......
$2500

Bronchopulmonary Dysplasia Global Clinical Trials Review, H2, 2018

Bronchopulmonary Dysplasia Global Clinical Trials Review, H2, 2018 Summary GlobalData's clinical trial report, "Bronchopulmonary Dysplasia Global Clinical Trials Review, H2, 2018" provides an overview of Bronchopulmonary Dysplasia clinical trials scenario. This report provides top line data relating to the clinical trials on Bronchopulmonary Dysplasia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary databas......
$2500

Chronic Bronchitis Global Clinical Trials Review, H2, 2018

Chronic Bronchitis Global Clinical Trials Review, H2, 2018 Summary GlobalData's clinical trial report, "Chronic Bronchitis Global Clinical Trials Review, H2, 2018" provides an overview of Chronic Bronchitis clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Bronchitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trial......
$2500

Bronchospasm Global Clinical Trials Review, H2, 2018

Bronchospasm Global Clinical Trials Review, H2, 2018 Summary GlobalData's clinical trial report, "Bronchospasm Global Clinical Trials Review, H2, 2018" provides an overview of Bronchospasm clinical trials scenario. This report provides top line data relating to the clinical trials on Bronchospasm. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical tri......
$2500
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy